Thiopentone Injection Ip 250 Mg/500mg/1gm/5 Mg Dry Powder Injections Vial

Thiopentone Injection Ip 250 Mg/500mg/1gm/5 Mg Dry Powder Injections Vial

Product Name :

Voriconazole Injection IP 200 Mg

Available Strength :

200 mg

Packing :

Vial / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Antifungal

Production Capacity :

Available on request

Description:

What is Thiopentone Injection IP?

Thiopentone Injection IP is specified as a dry powder injectable formulation containing thiopentone sodium, a short-acting barbiturate anaesthetic. It is used by qualified anaesthesia professionals for induction of general anaesthesia in appropriate clinical settings. The supplied strength list includes an unclear final entry, “5 Mg”, which should be verified before publication or ordering. All use must follow the approved product information.

Uses and Indications

Thiopentone sodium is a barbiturate anaesthetic used in specialist clinical settings. Depending on the approved product information and local clinical guidance, its uses may include:

  • Induction of general anaesthesia.

  • Selected specialist anaesthetic procedures.

  • Other specific uses only where authorised by the approved product information.

It is not suitable for unsupervised use and must only be administered by appropriately trained professionals with the necessary airway and resuscitation facilities.

Potential Benefits

  • Anaesthetic action: Produces rapid central nervous system depression when administered appropriately.

  • Clinical application: May be used for induction of general anaesthesia in selected patients.

  • Dry powder presentation: Requires preparation according to the product-specific instructions.

  • International sourcing support: Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries for international buyers.

Side Effects

Thiopentone can cause serious adverse effects, particularly if administered incorrectly or without appropriate monitoring.

Possible adverse effects include:

  • Respiratory depression or apnoea.

  • Reduced blood pressure.

  • Cardiovascular depression.

  • Drowsiness or delayed recovery.

  • Injection-site reactions.

  • Allergic reactions, including rare severe reactions.

Administration requires continuous clinical monitoring and immediate access to airway management, ventilation and resuscitation facilities.

How Does Thiopentone Work?

Thiopentone sodium is a barbiturate that enhances the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system. This depresses neuronal activity and can produce rapid unconsciousness. Its effects on breathing and cardiovascular function mean that administration requires specialist anaesthetic supervision.

Dosage Guidelines

  • Strengths supplied: 250 Mg, 500mg, 1gm and “5 Mg” as written in the product input.

  • The final strength entry must be clarified before the product catalogue is finalised.

  • Dose selection depends on the clinical indication, patient characteristics and approved product information.

  • Reconstitution and administration must follow the product-specific instructions and be performed by qualified anaesthesia professionals.

Do not infer a dose, diluent, reconstitution volume, concentration, route-specific preparation or stability period from the vial strength alone.

When Not to Use

Thiopentone may be contraindicated or unsuitable in patients with certain conditions, which can include:

  • Known hypersensitivity to thiopentone or formulation components.

  • Acute intermittent porphyria or other relevant porphyrias, according to approved product information.

  • Severe cardiovascular instability or other clinical circumstances in which its effects present unacceptable risk.

  • Any contraindication specified in the approved product documentation.

A specialist must assess the patient’s history and clinical condition before administration.

Drug and Product Interactions

Thiopentone may have additive effects with other medicines that depress the central nervous system or affect cardiovascular function.

Medicines requiring review may include:

  • Opioid analgesics.

  • Benzodiazepines and other sedatives.

  • Other general anaesthetic agents.

  • Antihypertensive medicines.

  • Other medicines that may affect respiratory or cardiovascular function.

The anaesthesia team should review all current medicines. Physical compatibility with other injectable products must be confirmed separately; do not mix medicines unless compatibility is documented.

Safety Advice

  • Administer only by appropriately trained anaesthesia professionals.

  • Ensure continuous monitoring and access to airway support, ventilation and resuscitation equipment.

  • Monitor respiratory and cardiovascular function throughout administration and recovery.

  • Confirm the correct product, strength and preparation instructions before use.

  • Do not use a vial if its integrity, identification or packaging is compromised.

General Instructions

  • Verify the product label and approved product specification before preparation.

  • Follow the specified reconstitution and administration instructions.

  • Do not assume compatibility with other injectable medicines.

  • Observe product-specific handling and in-use requirements.

  • Confirm the complete strength range, especially the supplied “5 Mg” entry, before publishing the listing.

Special Dietary and Lifestyle Tips

Thiopentone is used in a supervised clinical setting, so dietary advice is determined by the procedure and anaesthesia team.

  • Follow the anaesthetist’s pre-procedure fasting instructions.

  • Disclose alcohol use, sedatives, supplements and all prescribed medicines.

  • Follow post-anaesthesia instructions regarding driving, operating machinery and supervision.

  • Do not resume normal activities until cleared by the responsible clinical team.

Comparison with Other Treatments

Treatment General characteristics
Thiopentone sodium Short-acting barbiturate anaesthetic used for induction in selected clinical settings.
Propofol Intravenous anaesthetic agent with a different pharmacological profile.
Etomidate Intravenous induction agent that may be selected according to patient-specific clinical considerations.
Ketamine Anaesthetic agent with distinct effects and clinical considerations.

These agents are not directly interchangeable. Selection depends on the procedure, patient condition, clinician judgement and approved product information.

Precautions and Warnings

  • Thiopentone can cause profound respiratory and cardiovascular depression.

  • Administration requires trained personnel and appropriate monitoring and resuscitation facilities.

  • Review contraindications, allergies and concomitant medicines before use.

  • Verify the intended strength and preparation instructions before administration.

  • Do not infer regulatory approvals, certifications or manufacturing details without verified documentation.

  • Product details should be confirmed against the approved product specification.

Can I Use It With Other Medicines or Anaesthetics?

Thiopentone may be used as part of an anaesthetic regimen, but concurrent medicines require professional assessment.

  • Anaesthesia professionals should evaluate additive sedative, respiratory and cardiovascular effects.

  • Do not combine injectable medicines in the same container unless compatibility has been established.

  • Medicine selection and sequencing must follow the anaesthesia plan and approved product information.

Storage

Store Thiopentone Injection IP according to the approved product label and manufacturer’s instructions. The storage temperature, light-protection requirements, shelf life after reconstitution and in-use stability period have not been supplied and should not be assumed.

Frequently Asked Questions

1. What is Thiopentone Injection IP used for?

Thiopentone sodium is a short-acting barbiturate anaesthetic used for induction of general anaesthesia in selected clinical settings.

2. What strengths have been supplied?

The input lists 250 Mg, 500mg, 1gm and 5 Mg. The last entry should be confirmed because it may be incomplete or a typing error.

3. What is the dosage form?

The supplied dosage form is dry powder injection in a vial.

4. Who can administer thiopentone?

It should be administered by appropriately trained anaesthesia professionals with suitable monitoring and resuscitation facilities.

5. Does thiopentone require respiratory monitoring?

Yes. It can cause respiratory depression or apnoea and requires appropriate monitoring and airway support.

6. What are the storage requirements?

Storage conditions must be confirmed from the approved product label and specification.

7. Can international buyers enquire through Kelar Pharmachem India?

Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries. Availability, packing, documentation and supply terms can be confirmed on request.

Scroll to Top